Skip to content

Conversion of in Vitro Fertilization Cycles to Intrauterine Inseminations in Patients With a Poor Ovarian Response to Stimulation

Conversion of in Vitro Fertilization Cycles to Intrauterine Inseminations in Patients With a Poor Ovarian Response to Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03362489
Acronym
ConFIRM
Enrollment
462
Registered
2017-12-05
Start date
2018-01-10
Completion date
2024-03-14
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

In Vitro Fertilization, Intra-Uterine Insemination, Poor responders

Brief summary

The purpose of this study is to compare the efficiency of conversion to IUI and IVF in patients with a poor ovarian response to stimulation

Detailed description

In 5 to 10% of in vitro fertilization (IVF) cycles, a poor response to ovarian stimulation (defined as less than 4 mature follicles) is noted, even though high doses of exogenous gonadotropins are used. To date, there is no consensus on the ideal management strategy in poor responders. There are three therapeutic options available nowadays: 1. Oocyte retrieval is performed and the IVF cycle continued, despite the low number of mature follicles. 2. Conversion of the IVF cycle to an intrauterine insemination (IUI), on the condition of having at least one patent fallopian tube and good semen parameters. 3. Cancelation of the IVF cycle. In everyday practice, it is difficult for the physician to cancel the IVF cycle in the presence of 2, 3 or 4 mature follicles, especially following a lengthy stimulation. If live birth rates were comparable between IUI and IVF, conversion to IUI would be the better option for poor responders, since it would avoid an invasive procedure (oocyte retrieval) and the associated risk of complications, and is associated with at a lower cost. To our knowledge, no prospective randomized controlled trial comparing IVF to conversion to IUI in poor responders has been published to date. The studies published so far have been retrospective and observational, and had several methodological flaws. Therefore, we aimed to analyze whether conversion of IVF cycles to IUI in poor responders would result in the same live birth rates as oocyte retrievals followed by embryo transfers.

Interventions

PROCEDUREIVF / IVF-ICSI

In the IVF arm, oocyte retrieval is performed 36 hours after the HCG injection, in the operating room, under transvaginal ultrasound guidance, under local or general anesthesia. The procedure lasts about 20 minutes and the patients are discharged on the same day. The oocytes retrieved from the follicles are transported immediately to the lab for fertilization with the partner's sperm. Fertilization is done either via conventional IVF, or via ICSI, depending on the indication. Embryos are later transferred into the uterus on day 3 or day 5, under ultrasound guidance, in the outpatient department.

PROCEDUREIUI

In the conversion to IUI arm, IUI is performed 24 to 36 hours after ovulation trigger. The partner provides the sperm on site on the morning of the insemination, which is performed in the outpatient department.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Patients who accepted being included and signed the consent forms. * Age ≥18 years et \<43 years. * IVF cycle with and without Intra Cytoplasmic Sperm Injection (ICSI): * Conventional Agonist (long and short) or antagonist protocol, using urinary or recombinant gonadotropins. * Having only 2, 3 or 4 mature follicles (≥14 mm) on ovulation trigger day.

Exclusion criteria

* Confirmed bilateral tubal occlusion * Non-French speaking patients * Partners with severe oligoasthenoteratospermia (OATS) (\<5 millions motile spermatozoa in the ejaculate) * Suboptimal stimulation protocols: * Protocols ≤ 150 IU of daily gonadotropins * Mild stimulation protocols * Natural and modified natural cycle protocols * Women under legal guardianship * Women with no health or social security coverage * Women participating in other interventional trials

Design outcomes

Primary

MeasureTime frameDescription
The main criterion is the live birth rate12 monthsDefined as the birth of a living infant after 22 weeks gestational age (GA), or weighing ≥ 500 g.

Secondary

MeasureTime frameDescription
Neonatal complications12 MonthsNeonatal complications
Neonatal survival12 MonthsNeonatal survival
Multiple pregnancy rate7-8 WeeksDefined as more than two embryos visualized on ultrasound at 7 weeks GA.
Biochemical pregnancy rate5 WeeksDefined as serum HCG levels \>10 IU/L, 14 days after the IUI or the embryo transfer, followed by a rapid decrease until being undetectable.
Clinical pregnancy rate6-7 WeeksDefined as fetal cardiac activity at 6-7 weeks GA
Term at delivery12 MonthsTerm at delivery in Gestational age (GA)
All outcome measure will be further analyzed according to the number of follicles on trigger day (2, 3 or 4) and patients' age (<40 years vs. ≥40 years)12 MonthsAssess the impact of conversion to IUI, compared to IVF, on overall outcomes in in women with a poor ovarian response to stimulation, according to the number of follicles on trigger day (2, 3 or 4) and patients' age (\<40 years vs. ≥40 years)
All outcome measures will be further analyzed in the subgroup of women considered poor responders according to the Bologna criteria12 MonthsAssess the clinical efficiency of conversion to IUI, compared to IVF, in women considered poor ovarian responders according to the Bologna criteria
The rate of IVF cycles with empty follicle syndrome and no embryo transfers.1 WeekAnalyze the rate of IVF cycles with empty follicle syndrome and no embryo transfers
Cumulative clinical pregnancy and live birth rates in the IVF group, thus taking into account fresh and frozen embryos transferred in subsequent cycles12 MonthsAssess the impact of conversion to IUI, compared to IVF, on the cumulative clinical pregnancy and live birth rates - taking into account frozen embryo transfers in IVF - in women with a poor ovarian response to stimulation
Cost-efficiency analysis at 12 months12 MonthsCompare the cost-efficiency of both strategies at 12 months
Spontaneous pregnancy loss (PL) rate12 WeeksIncluding early and late pregnancy losses

Countries

France, Guadeloupe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026